Cargando…

Targeting DNA Damage Response in Prostate and Breast Cancer

Steroid hormone signaling induces vast gene expression programs which necessitate the local formation of transcription factories at regulatory regions and large-scale alterations of the genome architecture to allow communication among distantly related cis-acting regions. This involves major stress...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wengner, Antje M., Scholz, Arne, Haendler, Bernard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7663807/ https://www.ncbi.nlm.nih.gov/pubmed/33158305 http://dx.doi.org/10.3390/ijms21218273

Ejemplares similares

Exploiting Epigenetic Alterations in Prostate Cancer
por: Baumgart, Simon J., et al.
Publicado: (2017)

Dysregulated Transcriptional Control in Prostate Cancer
por: Baumgart, Simon J., et al.
Publicado: (2019)

From Omics to Multi-Omics Approaches for In-Depth Analysis of the Molecular Mechanisms of Prostate Cancer
por: Nevedomskaya, Ekaterina, et al.
Publicado: (2022)

Recent Advances in Prostate Cancer Treatment and Drug Discovery
por: Nevedomskaya, Ekaterina, et al.
Publicado: (2018)

Synergistic Effect of a Mesothelin-Targeted (227)Th Conjugate in Combination with DNA Damage Response Inhibitors in Ovarian Cancer Xenograft Models
por: Wickstroem, Katrine, et al.
Publicado: (2019)

Targeted thorium-227 conjugates as treatment options in oncology
por: Karlsson, Jenny, et al.
Publicado: (2023)

Targeting the epigenetics of the DNA damage response in breast cancer
por: Montenegro, M F, et al.
Publicado: (2016)

Therapeutic Targeting of DNA Damage Response in Cancer
por: Choi, Wonyoung, et al.
Publicado: (2022)

Targeting the DNA Damage Response for Cancer Therapy
por: Wang, Ruoxi, et al.
Publicado: (2023)

Enhanced Antitumor Efficacy of Radium-223 and Enzalutamide in the Intratibial LNCaP Prostate Cancer Model
por: Suominen, Mari I., et al.
Publicado: (2023)

Targeting DNA damage response in cancer therapy
por: Hosoya, Noriko, et al.
Publicado: (2014)

Targeting the DNA damage response for cancer therapy
por: Curtin, Nicola J.
Publicado: (2023)

Hormone-induced DNA damage response and repair mediated by cyclin D1 in breast and prostate cancer
por: Di Sante, Gabriele, et al.
Publicado: (2017)

Role of the DNA damage response in prostate cancer formation, progression and treatment
por: Zhang, Wenhao, et al.
Publicado: (2019)

Prostate-Specific Membrane Antigen Expression and Response to DNA Damaging Agents in Prostate Cancer
por: Sheehan, Beshara, et al.
Publicado: (2022)

Addressing the Reciprocal Crosstalk between the AR and the PI3K/AKT/mTOR Signaling Pathways for Prostate Cancer Treatment
por: Raith, Fabio, et al.
Publicado: (2023)

Darolutamide Potentiates the Antitumor Efficacy of a PSMA-targeted Thorium-227 Conjugate by a Dual Mode of Action in Prostate Cancer Models
por: Hammer, Stefanie, et al.
Publicado: (2021)

Targeting the DNA Damage Response Machinery for Lung Cancer Treatment
por: Venugopala, Katharigatta N.
Publicado: (2022)

Interplay of Developmental Hippo–Notch Signaling Pathways with the DNA Damage Response in Prostate Cancer
por: Mourkioti, Ioanna, et al.
Publicado: (2022)

Targeting the DNA Damage Response and DNA Repair Pathways to Enhance Radiosensitivity in Colorectal Cancer
por: Deng, Siyao, et al.
Publicado: (2022)

Targeting the DNA Damage Response to Overcome Cancer Drug Resistance in Glioblastoma
por: Ferri, Alessandra, et al.
Publicado: (2020)

Targeting the DNA damage response and repair in cancer through nucleotide metabolism
por: Helleday, Thomas, et al.
Publicado: (2022)

DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer
por: Huang, Rui-Xue, et al.
Publicado: (2020)

Beyond BRCA: The Emerging Significance of DNA Damage Response and Personalized Treatment in Pancreatic and Prostate Cancer Patients
por: Dalmasso, Bruna, et al.
Publicado: (2022)

Impact of DNA Damage Response—Targeted Therapies on the Immune Response to Tumours
por: Lutfi, Nura, et al.
Publicado: (2021)

PARP Inhibitors in Advanced Prostate Cancer in Tumors with DNA Damage Signatures
por: McNevin, Ciara S., et al.
Publicado: (2022)

Targeting DNA Damage Response and Immune Checkpoint for Anticancer Therapy
por: Huang, Jau-Ling, et al.
Publicado: (2022)

DNA damage response in prostate cancer cells by proton microbeam irradiation
por: Chen, Xue, et al.
Publicado: (2020)

DNA damage response and prostate cancer: defects, regulation and therapeutic implications
por: Karanika, Styliani, et al.
Publicado: (2014)

Targeting the DNA Damage Response Pathway as a Novel Therapeutic Strategy in Colorectal Cancer
por: Catalano, Fabio, et al.
Publicado: (2022)

DNA damage response proteins in canine cancer as potential research targets in comparative oncology
por: Hernández‐Suárez, Beatriz, et al.
Publicado: (2022)

Targeting Oxidatively Induced DNA Damage Response in Cancer: Opportunities for Novel Cancer Therapies
por: Davalli, Pierpaola, et al.
Publicado: (2018)

Strategies for targeting the DNA damage response for cancer therapeutics
por: Zhang, Dan, et al.
Publicado: (2012)

Correction to: Role of the DNA damage response in prostate cancer formation, progression and treatment
por: Zhang, Wenhao, et al.
Publicado: (2019)

Interplay between the DNA Damage Response and Immunotherapy Response in Cancer
por: Lee, Elizabeth Chun Yong, et al.
Publicado: (2022)

Targeting DNA Damage Response in the Radio(Chemo)therapy of Non-Small Cell Lung Cancer
por: Li, Ling, et al.
Publicado: (2016)

Targeting DNA Damage Response and Repair to Enhance Therapeutic Index in Cisplatin-Based Cancer Treatment
por: Kiss, Robert Csaba, et al.
Publicado: (2021)

Targeting DNA Damage Response and Replication Stress in Pancreatic Cancer
por: Dreyer, Stephan B., et al.
Publicado: (2021)

Sumoylation and the DNA Damage Response
por: Cremona, Catherine A., et al.
Publicado: (2012)

Autophagy in DNA Damage Response
por: Czarny, Piotr, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_2vikf1fn052kns900fg898av0t